Form 4 for LLY Lilly (Eli)
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001955972-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | LLY | Dozier Eric | EVP, CHRO | M - OptEx | $0.00 | +2,858 | 12.7K | +29% | $0 |
| D | 2026-02-03 | 2026-02-01 | LLY | Dozier Eric | EVP, CHRO | F - Tax | $1,037.15 | -1,273 | 11.4K | -10% | -$1.32M |
| D | 2026-02-03 | 2026-02-01 | LLY | Dozier Eric | EVP, CHRO | M - OptEx | $0.00 | -2,858 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 2,858 | $0.00 | 12,696.91 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 1,272.99 | $1,037.15 | 11,423.92 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-01 | M | D | 2,858 | $0.00 | 0 | D | — · 2026-02-01 to 2026-02-01 | 2,858 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |